Literature DB >> 29930010

CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Yuma Sakamoto1, Takashi Ishida2,3, Ayako Masaki1, Takayuki Murase1, Kentaro Yonekura4, Yukie Tashiro5, Masahito Tokunaga6, Atae Utsunomiya6, Asahi Ito3, Shigeru Kusumoto3, Shinsuke Iida3, Ryuzo Ueda7, Hiroshi Inagaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29930010     DOI： 10.1182/blood-2018-02-835991

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  29 in total

1.  Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Authors:  William Johnson; Anjali Mishra; Adam Binder; Alejandro Gru; Pierluigi Porcu
Journal:  Haematologica       Date:  2019-05       Impact factor: 9.941

2.  Identifying potential factors of variable response to mogamulizumab in adult T-cell leukemia/lymphoma between Japanese and other populations.

Authors:  Murali Janakiram; Milos D Miljkovic
Journal:  Haematologica       Date:  2019-05       Impact factor: 9.941

3.  CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma.

Authors:  Yuma Sakamoto; Keiichiro Fujii; Shunji Murase; Satsuki Nakano; Ayako Masaki; Takayuki Murase; Shigeru Kusumoto; Shinsuke Iida; Atae Utsunomiya; Ryuzo Ueda; Takashi Ishida; Hiroshi Inagaki
Journal:  Int J Hematol       Date:  2019-08-29       Impact factor: 2.490

4.  Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma.

Authors:  Masato Saito; Toshihiko Ishii; Itaru Urakawa; Asuka Matsumoto; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Susumu Suzuki; Takeshi Takahashi; Akimichi Morita; Hiroshi Inagaki; Shinsuke Iida; Takashi Ishida
Journal:  Blood Adv       Date:  2020-05-26

5.  What factors guide treatment selection in mycosis fungoides and Sezary syndrome?

Authors:  Youn H Kim
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

6.  Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Authors:  Kentaro Yonekura; Shigeru Kusumoto; Ilseung Choi; Nobuaki Nakano; Asahi Ito; Youko Suehiro; Yoshitaka Imaizumi; Makoto Yoshimitsu; Kisato Nosaka; Eiichi Ohtsuka; Michihiro Hidaka; Tatsuro Jo; Hidenori Sasaki; Yukiyoshi Moriuchi; Masao Ogata; Hiro Tatetsu; Kenji Ishitsuka; Yasushi Miyazaki; Ryuzo Ueda; Atae Utsunomiya; Takashi Ishida
Journal:  Blood Adv       Date:  2020-10-27

7.  Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab.

Authors:  Lucy B M Cook; Maria Antonietta Demontis; Sophie Sagawe; Aviva Witkover; Anat Melamed; Jocelyn Turpin; Richard Dillon; Jana Haddow; Alexandra J Marks; Charles R M Bangham; Paul Fields; Graham P Taylor; Aileen G Rowan
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

Review 8.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

9.  Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Authors:  Catalina Amador; Timothy C Greiner; Tayla B Heavican; Lynette M Smith; Karen Tatiana Galvis; Waseem Lone; Alyssa Bouska; Francesco D'Amore; Martin Bjerregaard Pedersen; Stefano Pileri; Claudio Agostinelli; Andrew L Feldman; Andreas Rosenwald; German Ott; Anja Mottok; Kerry J Savage; Laurence de Leval; Philippe Gaulard; Soon Thye Lim; Choon Kiat Ong; Sarah L Ondrejka; Joo Song; Elias Campo; Elaine S Jaffe; Louis M Staudt; Lisa M Rimsza; Julie Vose; Dennis D Weisenburger; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-12-12       Impact factor: 25.476

Review 10.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.